Glycemic control and organ transplantation

Journal of Diabetes Science and Technology

Volumn 3, Issue 6, 2009, Pages 1365-1372

  Marvin, Michael R ^a   Morton, Vicki ^b  

^a University of Louisville School of Medicine   (United States)

^b LifeSource Organ and Tissue Donation   (United States)

Author keywords

Hyperglycemia; Intensive glycemic control; Organ donor management; Transplantation

Indexed keywords

ANTIDIABETIC AGENT; IMMUNOSUPPRESSIVE AGENT; INSULIN;

ALLOTRANSPLANTATION; BLOOD; CRITICAL ILLNESS; DIABETES MELLITUS; DONOR; DRUG EFFECT; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE; LIVER TRANSPLANTATION; METABOLISM; ORGAN TRANSPLANTATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

BLOOD GLUCOSE; CRITICAL CARE; CRITICAL ILLNESS; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; GRAFT REJECTION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; LIVER TRANSPLANTATION; ORGAN TRANSPLANTATION; RISK ASSESSMENT; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77953293426     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680900300616     Document Type: Conference Paper

References (78)

1. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-67.
2. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-39.
3. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.
4. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007;35(10):2262-7. (Pubitemid 47476221)
5. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-61. (Pubitemid 43200296)
6. Devos P, Preiser J, Mélot C. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study. Intensive Care Med. 2007;33(Suppl 2):S189.
7. De La Rosa Gdel C, Donado JH, Restrepo AH, Quintero AM, González LG, Saldarriaga NE, Bedoya M, Toro JM, Velásquez JB, Valencia JC, Arango CM, Aleman PH, Vasquez EM, Chavarriaga JC, Yepes A, Pulido W, Cadavid CA, Grupo de Investigacion en Cuidado intensivo: GICI-HPTU. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12(5):R120.
8. Malmberg K, Rydén L, Efendic S, Herlitz J, Nicol P, Waldenström A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26(1):57-65.
9. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A, DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26(7):650-61.
10. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29(4):765-70. (Pubitemid 44115291)
11. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146(4):233-43. (Pubitemid 351650609)
12. Thomas MC, Mathew TH, Russ GR, Rao MM. Peri-operative hyperglycemia and increased allograft rejection in patients with diabetes. Kid Int. 2000.
13. Thomas MC, Moran J, Mathew TH, Russ GR, Rao MM. Early peri-operative hyperglycemia and renal allograft rejection in patients without diabetes. BMC Nephrol. 2000;1:1.
14. Ganji MR, Charkhchian M, Hakemi M, Nederi GH, Solymanian T, Saddadi F, Amini M, Najafi I. Association of hyperglycemia on allograft function in the early period after renal transplantation. Transplant Proc. 2007;39(4):852-4. (Pubitemid 46764872)
15. Van den Berg TJ, Bogers H, Vriesendorp TM, Surachno JS, DeVries JH, ten Berge IJ, Hoekstra JB. No apparent impact of increased postoperative blood glucose levels on clinical outcome in kidney transplant recipients. Clin Transplant. 2009;23(2):256-63.
16. Podrazik RM, Natale JE, Zelenock GB, D'Alecy LG. Hyperglycemia exacerbates and insulin fails to protect in acute renal ischaemia in the rat. J Surg Res. 1989;46(6):572-8. (Pubitemid 19170323)
17. Panés J, Kurose I, Rodriguez-Vaca MD, Anderson DC, Miyasaka M, Tso P, Granger DN. Diabetes exacerbates inflammatory responses to ischaemia-reperfusion. Circulation. 1996;93:161-7.
18. Rutault K, Alderman C, Chain BM, Katz DR. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med. 1999;26(1-2):232-8.
19. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G. Leucocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in an NF-kB-dependent fashion. J Clin Invest. 1998;101(9):1905-15. (Pubitemid 28226110)
20. Takami S, Yamashita S, Kihara S, Kameda-Takemura K, Matsuzawa Y. High concentration of glucose induces expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells. Atherosclerosis. 1998;138(1):35-41. (Pubitemid 28255152)
21. Marvin MR, Rocca JP, Farrington E, Shi Q, Babu R, Desai N, Valiquette V, Bergman M, Rodriguez MD, Facciuto ME, Sheiner PA. Intensive perioperative insulin therapy in liver transplant patients - effective implementation with a computer-based dosage calculator. Am J Transplant. 2006;6(S2):986.
22. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27(2):461-7. (Pubitemid 38174072)
23. Hsaiky LM, Bajjoka IE, Patel D, Abouljoud MS. Postoperative use of intense insulin therapy in liver transplant recipients. Am J Transplant. 2007;7(S2):194.
24. Hsaiky LM, Bajjoka IE, Patel D, Abouljoud MS. Postoperative use of intense insulin therapy in liver transplant recipients. Am J Transplant. 2008;8(S2):260.
25. Ammori JB, Sigakis M, Englesbe MJ, O'Reilly M, Pelletier SJ. Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res. 2007;140(2):227-33. (Pubitemid 46726378)
26. Park C, Hsu C, Neelakanta G, Nourmand H, Braunfeld M, Wray C, Steadman RH, Hu KQ, Cheng RT, Xia VW. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation. 2009;87(7):1031-6.
27. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 1974;23(1):9-15.
28. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26(3-4):259-65.
29. Kwoun MO, Ling PR, Lydon E, Imrich A, Qu Z, Palombo J, Bistrian BR. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr. 1997;21(2):91-5. (Pubitemid 27136782)
30. Losser MR, Bernard C, Beaudeux JL, Pison C, Payen D. Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits. J Appl Physiol. 1997;83(5):1566-74. (Pubitemid 27495332)
31. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. Am J Med. 1982;72(3):439-50. (Pubitemid 12188680)
32. Sima AA, O'Neill SJ, Naimark D, Yagihashi S, Klass D. Bacterial phagocytosis and intracellular killing by alveolar macrophages in BB rats. Diabetes. 1988;37(5):544-9.
33. Tirone TA, Brunicardi FC. Overview of glucose regulation. World J Surg. 2001;25(4):461-7. (Pubitemid 32455199)
34. Van Hooff JP, Christiaans MH, van Duijnhoven EM. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant. 2004;19 Suppl 6:vi8-vi12. (Pubitemid 40057665)
35. Boots JM, van Duijnhoven EM, Christiaans MH, Wolffenbuttel BH, van Hooff JP. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol. 2002;13(1):221-7. (Pubitemid 34042031)
36. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care. 2002;25(3):583-92.
37. Heisel O, Heisel R, Balshaw B, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant. 2004;4(4):583-95. (Pubitemid 38523581)
38. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report - 2007. J Heart Lung Transplant. 2007;26(8):782-95. (Pubitemid 47199080)
39. Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD. Posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant. 2008;8(1):175-82.
40. Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, Stegall MD. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 2005;67(6):2415-21. (Pubitemid 41623405)
41. Sato T, Inagaki A, Uchida K, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Tominaga Y, Okajima Y, Ohta K, Suga H, Taguchi S, Kakiya S, Itatsu T, Kobayashi T, and Nakao A. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation. 2003;76(9):1320-6. (Pubitemid 37430718)
42. Nam JH, Mun JI, Kim SI, Kang SW, Choi KH, Park K, Ahn CW, Cha BS, Song YD, Lim SK, Kim KR, Lee HC, Huh KB. Beta-cell dysfunction rather than insulin resistance is the main contributing factor for development of postrenal transplantation diabetes mellitus. Transplantation. 2001;71(10):1417-23. (Pubitemid 32507115)
43. Ekstrand A, Ahonen J, Grönhagen-Riska C, Groop L. Mechanisms of insulin resistance after kidney transplantation. Transplantation. 1989;48(4):563-8. (Pubitemid 19267468)
44. Hougardy DM, Peterson GM, Bleasel MD, Randall CT. Is enough attention being given to the adverse effects of corticosteroid therapy? J Clin Pharm Ther. 2000;25(3):227-34. (Pubitemid 30495314)
45. Braithwaite SS, Barr WG, Rahman A, Quddusi S. Managing diabetes during glucocorticoid therapy. How to avoid metabolic emergencies. Postgrad Med. 1998;104(5):163-6, 171, 175-6.
46. Hoogwerf B, Danese RD. Drug selection and the management of corticosteroid-related diabetes mellitus. Rheum Dis Clin North Am. 1999;25(3):489-505. (Pubitemid 29400386)
47. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med. 1994;154(1):97-101. (Pubitemid 24018107)
48. Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006;12(4):358-62. (Pubitemid 44717593)
49. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci (Lond). 1999;96(5):513-23. (Pubitemid 29237902)
50. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med. 2006;119(5 Suppl 1): S10-6.
51. Midtvedt K, Hjelmesaeth J, Hartmann A, Lund K, Paulsen D, Egeland T, Jenssen T. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol. 2004:15(12);3233-9. (Pubitemid 39578856)
52. Weir MR, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999;34(1):1-13. (Pubitemid 29318789)
53. Drachenberg CB, Klassen DK, Weir MR, Wiland A, Fink JC, Bartlett ST, Cangro CB, Blahut S, Papadimitriou JC. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation. 1999;68(3):396-402. (Pubitemid 29384108)
54. Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B, Eigler FW, Heemann U, Pichlmayr R, Behrend M, Vanrenterghem Y, Donck J, van Hooff J, Christiaans M, Morales JM, Andres A, Johnson RW, Short C, Buchholz B, Rehmert N, Land W, Schleibner S, Forsythe JL, Talbot D, Pohanka E. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation. 1997;64(3):436-43. (Pubitemid 27349884)
55. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS, FK506 Kidney Transplant Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation. 1997;63(7):977-83. (Pubitemid 27173021)
56. Shapiro R, Jordan M, Scantlebury V, Fung J, Jensen C, Tzakis A, McCauley J, Carroll P, Ricordi C, Demetris AJ, Mitchell S, Jain A, Iwaki Y, Kobayashi M, Reyes J, Todo S, Hakala TR, Simmons RL, Starzl TE. FK 506 in clinical kidney transplantation. Transplant Proc. 1991;23:3065-7.
57. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003;3(2):178-85. (Pubitemid 36323115)
58. Sumrani NB, Delaney V, Ding ZK, Davis R, Daskalakis P, Friedman EA, Butt KM, Hong JH. Diabetes mellitus after renal transplantation in the cyclosporine era: an analysis of risk factors. Transplantation. 1991;51(2):343-7.
59. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol. 2005;16(2):496-506. (Pubitemid 41725147)
60. Ducloux D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study. Transplantation. 2005;79(4):438-43. (Pubitemid 40280176)
61. Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant. 2001;15(2):89-94. (Pubitemid 32229796)
62. Bodziak KA, Hricik DE. New-onset diabetes mellitus after solid organ transplantation. Transpl Int. 2009;22(5):519-30.
63. Miles AM, Sumrani N, Horowitz R, Homel P, Maursky V, Markell MS, Distant DA, Hong JH, Sommer BG, Friedman EA. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation.1998;65(3):380-4. (Pubitemid 28095966)
64. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc. 1997;29(8):3770-2. (Pubitemid 28008681)
65. Tuttle-Newhall JE, Collins BH, Kuo PC, Schoeder R. Organ donation and treatment of the multi-organ donor. Curr Probl Surg. 2003;40(5):266-310. (Pubitemid 36553294)
66. Lagiewska B, Pacholczyk M, Szostek M, Wa?aszewski J, Rowi?ski W. Hemodynamic and metabolic disturbances observed in brain-dead organ donors. Transplant Proc. 1996;28(1):165-6. (Pubitemid 26073683)
67. Amado JA, López-Espadas F, Vázquez-Barquero A, Salas E, Riancho JA, López-Cordovilla JJ, García-Unzueta MT. Blood levels of cytokines in brain-dead patients: relationship with circulating hormones and acute phase reactants. Metabolism. 1995;44(6):812-6.
68. Zivna H, Zivny P, Navratil P, Palicka V, Cerny V, Holeckova M, Pliskova L. The role of cytokines and antioxidant status in graft quality prediction. Transplant Proc. 1999;31(5):2094. (Pubitemid 29376536)
69. Masson F, Thicoipe M, Gin H, de Mascarel A, Angibeau RM, Favarel-Garrigues JF, Erny P. The endocrine pancreas in brain-dead donors. A prospective study in 25 patients. Transplantation. 1993;56(2):363-7. (Pubitemid 23239442)
70. Howlett TA, Keogh AM, Perry L, Touzel R, Rees LH. Anterior and posterior pituitary function in brain-stem-dead donors. A possible role for hormonal replacement therapy. Transplantation. 1989;47(5):828-34. (Pubitemid 19139122)
71. Gramm HJ, Meinhold H, Bickel U, Zimmermann J, von Hammerstein B, Keller F, Dennhardt R, Voigt K. Acute endocrine failure after brain death? Transplantation. 1992;54(5):851-7.
72. Sazontseva IE, Kozlov IA, Moisuc YG, Ermolenko AE, Afonin VV, Ilnitskiy VV. Hormonal response to brain death. Transplant Proc. 1991;23(5):2467.
73. Figueras J, Busquets J, Grande L, Jaurrieta E, Perez-Ferreiroa J, Mir J, Margarit C, Lopez P, Vazquez J, Casanova D, Bernardos A, De-Vicente E, Parrilla P, Ramon JM, Bou R. The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis. Transplantation. 1996;61(3):410-3. (Pubitemid 26067916)
74. González FX, Rimola A, Grande L, Antolin M, Garcia-Valdecasas JC, Fuster J, Lacy AM, Cugat E, Visa J, Rodés J. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology. 1994;20(3):565-73.
75. Totsuka E, Dodson F, Urakami A, Moras N, Ishii T, Lee MC, Gutierrez J, Gerardo M, Molmenti E, Fung JJ. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg. 1999;5(5):421-8. (Pubitemid 29437020)
76. Blasi-Ibanez A, Hirose R, Feiner J, Freise C, Stock PG, Roberts JP, Niemann CU. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit Anesthesiology. 2009;110(2):333-41.
77. Nunnally ME, O'Connor MF. Glycemic control for organs: a new approach to a controversial topic. Anesthesiology. 2009;110(2):207-8.
78. Personal communication from Claus Niemann, M.D., University of California, San Francisco.